HIV-1, reactive oxygen species, and vascular complications
about
Hydrogen Sulfide and Cellular Redox HomeostasisDrug-drug interactions between anti-retroviral therapies and drugs of abuse in HIV systemsMechanisms Underlying HIV Associated Non-infectious Lung Disease.Resveratrol Co-Treatment Attenuates the Effects of HIV Protease Inhibitors on Rat Body Weight and Enhances Cardiac Mitochondrial Respiration.The Role of Caveolin 1 in HIV Infection and Pathogenesis.Microvascular Endothelial Dysfunction and Enhanced Thromboxane and Endothelial Contractility in Patients with HIV.Human immunodeficiency virus-1 (HIV-1)-mediated apoptosis: new therapeutic targets.Ligand-Independent Activation of Platelet-Derived Growth Factor Receptor β during Human Immunodeficiency Virus-Transactivator of Transcription and Cocaine-Mediated Smooth Muscle Hyperplasia.The ABCs of Trait Anger, Psychological Distress, and Disease Severity in HIV.Hydrogen-Rich Saline as an Innovative Therapy for Cataract: A Hypothesis.Role of oxidative stress in infectious diseases. A review.Reactive oxygen and nitrogen species during viral infections.Maintaining lung health with longstanding HIV.The HIV-1 Vpr Protein: A Multifaceted Target for Therapeutic Intervention.The potential toxicological insights about the anti-HIV drug azidothymidine-derived monoselenides in human leukocytes: Toxicological insights of new selenium-azidothymidine analogs.Fusion to Flaviviral Leader Peptide Targets HIV-1 Reverse Transcriptase for Secretion and Reduces Its Enzymatic Activity and Ability to Induce Oxidative Stress but Has No Major Effects on Its Immunogenic Performance in DNA-Immunized Mice.Infectious Agents in Atherosclerotic Cardiovascular Diseases through Oxidative Stress.Baseline Cigarette Smoking Status as a Predictor of Virologic Suppression and CD4 Cell Count During One-Year Follow-Up in Substance Users with Uncontrolled HIV Infection.HIV and Cardiovascular Disease: Role of Immunometabolic Perturbations.
P2860
Q26765798-DB7247E0-CFA3-4E0C-B782-9039D34E14A5Q26851241-CF7516D4-9D6A-412F-ADAB-FB139B258921Q30234727-8E371030-124F-4B88-9F44-EE614DDDAB87Q30397743-7574A51F-F702-44AD-BD36-6905FB62C399Q32183747-E87E58C5-D18A-4D19-808E-CAF88397ED77Q33792101-323B08BE-E9E7-4C30-A74F-D9452FA55F34Q34664366-622396BA-8DF5-406B-AA1E-49BABF3731BEQ36049297-05124090-7E09-4A48-B79A-4BDC4A0B3FBFQ36215709-8C6B30BB-2714-49B4-BA98-3ED19532B640Q37248408-5B918986-2B53-40B4-9D58-FCC1D6B6CB90Q38090568-658760F8-2FAD-4334-9E94-9CEAB37B3ADDQ38231321-BAE368C2-7261-4863-ADD1-512BB4B9B9B3Q38629654-DCC0F854-CCDF-425C-89BD-78AF1EF884E3Q39079514-C418E752-A31B-4F5B-98FA-8B7D65D95DECQ39253034-E75EC243-CC7A-40DC-9F82-393C1B3189E0Q40119086-E7CE0211-BC01-44B2-9333-C4E118D520C4Q46257956-AE19E7C5-15D2-480F-8F84-AB67BA108187Q46627355-6B09DEA7-C43F-4F66-958B-A9B384C30853Q50045865-C4E11F34-8469-4C64-820C-B03E2325C5FD
P2860
HIV-1, reactive oxygen species, and vascular complications
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
HIV-1, reactive oxygen species, and vascular complications
@ast
HIV-1, reactive oxygen species, and vascular complications
@en
type
label
HIV-1, reactive oxygen species, and vascular complications
@ast
HIV-1, reactive oxygen species, and vascular complications
@en
prefLabel
HIV-1, reactive oxygen species, and vascular complications
@ast
HIV-1, reactive oxygen species, and vascular complications
@en
P2860
P1476
HIV-1, reactive oxygen species, and vascular complications
@en
P2093
Kristi M Porter
Roy L Sutliff
P2860
P304
P356
10.1016/J.FREERADBIOMED.2012.03.019
P577
2012-04-21T00:00:00Z